Pre-Surgery nutrition shakes may cut complications for IBD patients
NCT ID NCT06309017
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether improving nutrition before surgery reduces complications in people with inflammatory bowel disease (IBD). About 150 adults scheduled for intestinal surgery will receive a nutrition specialist and special shakes. Researchers will track hospital stay length and major problems like infection or bleeding.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- nutritional counseling and Ensure Surgery Immunonutrition shakes
- What this could lead to
- If successful, this could establish a standard pre-surgery nutrition plan that lowers infection, bleeding, and other major complications for IBD patients.
- What could go wrong
- This is a single-center study with 150 participants, so results may not apply to all hospitals or patients. The nutrition shakes are already standard of care, so the added benefit may be small.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 150 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2025
- Expected to finish
-
Jul 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Able and willing to provide written informed consent 2. Aged 18 years of age or older 3. Confirmed diagnosis of inflammatory bowel disease 4. Scheduled for disease-related intestinal resection at NYU Langone Health Exclusion Criteria: 1. No current diagnosis of inflammatory bowel disease 2. Age less than 18 3. Not proficient (able to read and answer questions) in English
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Inflammatory bowel diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a cheap Anti-Inflammatory drug calm ulcerative colitis?
- Can early symptom relief predict who stays on IBD biologic?
- Can a liquid diet calm Crohn's in kids?
- Which IBD therapy works best for kids? researchers compare two approaches
- Massive Real-World database aims to map how chronic diseases interact
- Staph bacteria may hold clues to painful skin rashes in IBD patients on Anti-TNF therapy